Journal
JOURNAL OF LARYNGOLOGY AND OTOLOGY
Volume 133, Issue 5, Pages 394-398Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0022215119000689
Keywords
Th17 Cells; Laryngeal Neoplasm; IL-17A; IL-23
Categories
Funding
- Scientific Research Fund of Yildirim Beyazit University [1738]
Ask authors/readers for more resources
Objective To explore the role of T-helper 17 cells and their cascade in the pathogenesis of laryngeal cancer. Methods Prospectively, 110 consecutive patients with a suspicious laryngeal lesion were evaluated for serum levels of T-helper 17 cell related interleukins, including interleukins 23, 17A and 22, determined by enzyme-linked immunosorbent assay. The patients were divided into 2 groups after pathological evaluation: 49 patients with malignancy and 61 with benign pathology. Associations between interleukin levels and malignancy were determined via correlation analyses. Results Interleukin 17A and 22 levels were significantly higher in the malignancy group than the benign lesion group. Pearson correlation analysis showed that interleukins 17A and 22 acted in a cascade, but interleukin 23 did not. According to predictive values, interleukin 17A levels were 3.87 times and interleukin 22 levels were 1.09 times more likely to be associated with laryngeal cancer. The cut-off values for predicting laryngeal cancer were 3.55 pg/ml for interleukin 17A and 119.82 pg/ml for interleukin 22. Conclusion T-helper 17 cell related interleukins are potential biomarkers that may be helpful in diagnosing laryngeal cancer. Moreover, these data may support neutralisation of T-helper 17 cell related cytokine activity, which could be an attractive strategy for treating laryngeal cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available